SFS
VNDA icon

Sowell Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History

Sowell Financial Services’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,156
Closed -$20K – 2669
2021
Q1 		$20K Hold
1,156
– – ﹤0.01% 2069
2020
Q4 		$15K Buy
+1,156
New +$13.9K ﹤0.01% 1868

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Sowell Financial Services's VNDA Position: Q2 2021 in Review

Sowell Financial Services sold out of Vanda Pharmaceuticals (VNDA) in Q2 2021, closing a stake of 1,156 shares — an estimated $20K sold.

Sowell Financial Services first reported a position in VNDA in Q4 2020 and held it in 2 quarters. The position peaked at $20K in Q1 2021. 181 funds tracked by Wall St. Rank hold VNDA as of Q2 2021.

  • Sowell Financial Services reported no remaining Vanda Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,156 Vanda Pharmaceuticals shares in Q2 2021, an estimated $20K.
  • Sowell Financial Services first reported a position in Vanda Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Vanda Pharmaceuticals position peaked at $20K in Q1 2021.
  • 181 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.